TransDigm (TDG) insider files to sell 15,600 shares after option exercise
Rhea-AI Filing Summary
TransDigm Group insider plans a Rule 144 share sale. A person identified as JOEL B REISS filed to sell 15,600 shares of TransDigm common stock through Morgan Stanley Smith Barney, with an aggregate market value of 20,072,052.00, on or about 02/17/2026 on the NYSE.
The shares were acquired the same day via an exercise of stock options for cash. The notice states there were 56,473,563 common shares outstanding. Over the prior three months, the filer’s 10b5-1 sales included 3,900 shares on 01/15/2026 for gross proceeds of 5,576,694.63 and 3,900 shares on 12/15/2025 for 5,033,033.46.
Positive
- None.
Negative
- None.
Insights
Form 144 shows planned insider stock sales alongside option exercise.
The filing outlines a planned sale of 15,600 TransDigm common shares under Rule 144, executed via Morgan Stanley. These shares come from a same-day stock option exercise paid in cash, which is a common way for insiders to realize compensation value.
The document notes 56,473,563 common shares outstanding, giving context for the sale’s scale without quantifying its proportion. It also lists earlier 10b5-1 sales of 3,900 shares each on 12/15/2025 and 01/15/2026 with specified gross proceeds amounts.
Because the transactions follow Rule 144 and, in part, a 10b5-1 framework, they fit standard insider liquidity practices. Future company filings may provide additional detail on any further option exercises or sales, but this notice by itself represents routine administrative disclosure.